Cansino Ceo On China's Pharma Outlook

CanSino CEO on China's Pharma Outlook

Bloomberg Television

China 'Definitely' Needs 2nd Covid Booster Dose: CanSino Biologics CEO

Bloomberg Television

Interview with CanSinoBIO's CEO: Get to know China's first single-dose vaccine

CGTN

Indian Court Reduced Drug Price from $69,000 to $177! 2024 📉

Bane Motivation

Tariffs could have trickle-down effects across global pharmaceutical industry, says CEO

CNBC International News

AstraZeneca CEO Soriot on Pharmaceuticals in China

Bloomberg Television

BeiGene CEO on Coronavirus Impact, China Biopharma, Product Pipeline

Bloomberg Television

Shionogi Covid Pill May Get China Approval in March: CEO

Bloomberg Television

Madrigal Pharma CEO talks competition in the GLP-1 space and new drug rollouts

CNBC Television

Pakistan will soon locally produce China's CanSino COVID-19 vaccine.

PAK INFO CHANNEL

CanSino Biologics Inhaled COVID Vaccine Gets Chinese Emergency Use Nod as Booster

Medical Dialogues

Outlook: Investing in China's Life Sciences Sector

Pharmaceutical Executive Magazine

Cansino Unit Gets $117.2MLN to Build Covid Vaccine Production Line #Shorts

International Channel Shanghai

Top Indian Pharmaceutical Companies #shorts #pharmaceuticals #viralshorts

Pharmaguideline

Focus on supply chain and manufacturing in expansion plans: Telix Pharma CEO

CNBC International News

GlaxoSmithKline's CEO on the China Controversy, Transparency, and Big Pharma's Reputation | Forbes

There Is a Bright Future in China Biotech: Loncar Investments’s CEO

Bloomberg Television

Is Jeff Bezos Really That Approachable #wealth #jeffbezos #celebrity #entrepreneur #ceo

China develops inhaled COVID-19 vaccine

Direct message to the CEO of Otsuka Pharmaceuticals

Minerva of peace